All eyes on Revolution, bispecific antibodies and more at ASCO26
BioSpace
Partners Summit Therapeutics and Akeso are expected to steal the show at the American Society of Clinical Oncology's annual conference with data from their potential Keytruda rival, alongside Revoluti
pharminent
May 26, 2026 (Last updated: May 26, 2026)
BioSpace
Partners Summit Therapeutics and Akeso are expected to steal the show at the American Society of Clinical Oncology’s annual conference with data from their potential Keytruda rival, alongside Revoluti
